|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/20 | (2006.01) |
| A61K 31/4045 | (2006.01) |
| (11) | Number of the document | 2919766 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13798840.8 |
| Date of filing the European patent application | 2013-11-14 | |
| (97) | Date of publication of the European application | 2015-09-23 |
| (45) | Date of publication and mention of the grant of the patent | 2021-05-26 |
| (46) | Date of publication of the claims translation | 2021-09-27 |
| (86) | Number | PCT/US2013/070012 |
| Date | 2013-11-14 |
| (87) | Number | WO 2014/078486 |
| Date | 2014-05-22 |
| (30) | Number | Date | Country code |
| 201261726893 P | 2012-11-15 | US | |
| 201361769408 P | 2013-02-26 | US |
| (72) |
NI, Yong, US
PARIKH, Bhavnish, US
YELESWARAM, Krishnaswamy, US
ERICKSON-VIITANEN, Susan, US
WILLIAMS, William V., US
|
| (73) |
Incyte Holdings Corporation,
1801 Augustine Cut-Off, Wilmington, DE 19803,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Ruksolitinibo pailginto atpalaidavimo vaisto formos |
| SUSTAINED-RELEASE DOSAGE FORMS OF RUXOLITINIB |
| Payment date | Validity (years) | Amount | |
| 2024-11-06 | 12 | 289.00 EUR |
| 2025-11-14 |